Type 1 diabetes is caused by the immune system attacking and destroying the insulin-producing cells in the pancreas. These cells, called beta cells, are the body’s only source of insulin, and once enough of them are gone, blood sugar can no longer be regulated without injected insulin. The destruction doesn’t happen overnight. It unfolds over months or years before symptoms appear, driven by a combination of genetic susceptibility, environmental triggers, and an immune system that loses the ability to tell friend from foe.
The Autoimmune Attack on the Pancreas
In a healthy body, immune cells ignore the pancreas entirely. In type 1 diabetes, certain white blood cells begin treating beta cells as foreign invaders. Dendritic cells, which act as scouts for the immune system, present fragments of beta cell proteins to other immune cells, essentially flagging them as threats. This activates a targeted attack, with specialized immune cells called CD8 T lymphocytes infiltrating clusters of beta cells (known as islets) and killing them one by one.
What’s striking is how little immune activity it takes. Studies of pancreatic tissue show that fewer than 10% of islets become infiltrated, with as few as 15 immune cells per islet needed to cause damage. That’s only about double the number found in a healthy pancreas. This slow, low-grade assault is why the disease can simmer for years before enough beta cells are lost to cause noticeable symptoms. By the time someone is diagnosed, the vast majority of their beta cells are already gone, with roughly 5% still functioning.
Genetics Set the Stage
Type 1 diabetes runs in families, but not as strongly as most people assume. Your genes don’t cause the disease directly. Instead, they determine how vulnerable your immune system is to misfiring against your own cells.
The most important genetic region is a set of genes called HLA, which controls how the immune system identifies threats. Two variants in particular, HLA-DR3 and HLA-DR4, are found in most white people with type 1 diabetes. In other populations, different variants play a similar role: HLA-DR7 is linked to risk in African Americans, and HLA-DR9 in Japanese populations. Beyond HLA, researchers have identified additional gene regions that influence risk, many of which affect how T cells (the immune cells that carry out the attack) function and are regulated.
The family risk statistics help put genetics in perspective. If a father has type 1 diabetes, each of his children has about a 1 in 17 chance of developing it. If a mother has it and gave birth before age 25, the child’s risk is about 1 in 25. If she gave birth after 25, the risk drops to 1 in 100. The risk roughly doubles if the parent was diagnosed before age 11. These numbers make one thing clear: even with a strong family history, the majority of children don’t develop the disease. Something beyond genes has to pull the trigger.
Viral Infections as a Trigger
The leading environmental suspect is viral infection, particularly a family of common gut viruses called enteroviruses. One specific type, coxsackievirus, has received the most attention. In a landmark study, researchers examined pancreatic tissue from six people within weeks of their type 1 diabetes diagnosis. All six showed signs of enteroviral infection inside their islets, along with heightened immune activation. Only a small fraction of control subjects without diabetes showed similar findings.
The proposed chain of events works like this: a viral infection in a genetically susceptible person triggers an inflammatory response in the pancreas. The infection causes beta cells to display more of their internal proteins on their surface, essentially making themselves more visible to the immune system. In someone whose immune system is already prone to overreacting (because of their HLA genes or other genetic factors), this increased visibility leads immune cells to recognize beta cell proteins as foreign. Autoreactive T cells begin infiltrating the islets, and the slow process of destruction begins.
Researchers have also shown that coxsackieviruses can persist in the pancreas in a low-level, slow-replicating form for weeks after the initial infection. This lingering presence may keep the immune system agitated long enough for the autoimmune process to become self-sustaining, continuing even after the virus itself is cleared.
The Hygiene Hypothesis and Early Microbial Exposure
Type 1 diabetes rates have been climbing steadily in developed countries, faster than genetics alone could explain. One theory for this rise focuses on changes in early childhood microbial exposure. The idea, sometimes called the hygiene hypothesis, is that a less diverse gut microbiome in infancy may leave the immune system poorly calibrated, making it more likely to attack the body’s own tissues.
Animal research supports this. Mice genetically prone to type 1 diabetes develop the disease faster when raised in ultra-clean, pathogen-free environments compared to mice housed under normal conditions. Even more telling, when researchers wiped out the gut bacteria of these mice with broad-spectrum antibiotics, their risk of developing diabetes increased significantly. The implication is that a healthy, diverse community of gut bacteria during early life helps train the immune system to tolerate the body’s own cells. Factors like antibiotic use in infancy, changes in diet, and reduced exposure to a wide range of microbes during the first years of life may all contribute to the rising rates seen in recent decades.
Vitamin D and Other Nutritional Factors
Vitamin D has drawn attention because of its role in immune regulation. Several large analyses of observational studies suggest that vitamin D supplementation during infancy may offer some protection against developing type 1 diabetes later in childhood. The timing matters: evidence for a protective effect during pregnancy is inconsistent, with some studies finding lower maternal vitamin D levels linked to higher risk in offspring and others finding no connection. The stronger signal appears to come from supplementation after birth, during the window when the infant’s immune system is rapidly developing.
This doesn’t mean vitamin D deficiency causes type 1 diabetes on its own. It’s more likely one of many environmental factors that can nudge an already-susceptible immune system in the wrong direction.
How the Disease Is Confirmed
Because the autoimmune attack begins long before symptoms show up, it leaves detectable traces in the blood. The immune system produces autoantibodies, proteins that target specific components of beta cells. Four have been identified as reliable markers: autoantibodies against insulin, an enzyme called glutamate decarboxylase, a protein called IA-2, and zinc transporter 8.
Current guidelines use what’s known as “the rule of twos” to identify someone in the early stages: at least two different autoantibodies must be detected, in two separate blood samples, ideally using two different testing methods. A person who tests positive for two or more autoantibodies is considered to have early-stage type 1 diabetes, even if their blood sugar is still normal. This is the presymptomatic phase, and it can last months to years before enough beta cells are destroyed to cause high blood sugar.
The Honeymoon Phase After Diagnosis
Because beta cell destruction is gradual, many people still have a small number of functioning cells at the time of diagnosis. This leads to a temporary period often called the honeymoon phase, during which the remaining beta cells continue producing some insulin. Blood sugar may be easier to manage, and insulin needs can drop noticeably.
The honeymoon phase most commonly lasts a few months to a year, though some people experience it for several years. It always ends eventually, as the immune system continues its attack on the remaining cells. Understanding this phase is important because the temporary improvement can be confusing. It doesn’t mean the diagnosis was wrong or that the disease is reversing.
When Type 1 Diabetes Starts in Adulthood
Type 1 diabetes is often thought of as a childhood disease, but the same autoimmune process can begin much later. When it develops slowly in adults, typically after age 30, it’s called latent autoimmune diabetes in adults, or LADA. The underlying cause is identical: the immune system destroys beta cells. The key difference is pace. In LADA, the destruction happens gradually enough that the pancreas still produces meaningful amounts of insulin for months or even years after onset.
This slow progression creates a diagnostic problem. Because adults with LADA still make some insulin early on, and because they often don’t fit the expected profile of a type 1 patient, many are initially misdiagnosed with type 2 diabetes. The distinction matters because type 2 treatments that stimulate the pancreas to work harder can accelerate beta cell burnout in someone whose real problem is autoimmune destruction. Autoantibody testing is the clearest way to tell the two apart.